Bangkok Dusit Medical Services Public Company Limited (BDUUF) Research

Bangkok Dusit Medical Services Public Company Limited (BDMS), together with its affiliated companies, operates as a leading healthcare provider. The company manages an extensive network of 47 hospitals located across both Thailand and Cambodia. Its diverse portfolio includes six prominent hospital brands: Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond its core medical facilities, BDMS offers integrated health and wellness services, such as holistic clinical wellness, skin and aesthetics telemedicine, and genome sequencing. The group also maintains a broad array of other business interests. These span hospitality (operating hotels and restaurants) and the retail of health and cosmetic merchandise. Furthermore, BDMS provides various professional services, including accounting, health insurance, laboratory diagnostics, investment management, information technology, training, insurance brokerage, air medical transportation, as well as facility, property, and asset management. The company is also active in the manufacturing and distribution of medicines and pharmaceutical products, in addition to e-commerce and real estate development. Established in 1969, Bangkok Dusit Medical Services Public Company Limited is headquartered in Bangkok, Thailand.

Market snapshot

Symbol
BDUUF
Price
$0.64
Day change
0.00%
Market cap
$290.8B
P/E ratio
18.69x
52-week range
0.59-0.66
Sector
Healthcare
Industry
Medical - Care Facilities

Peer companies

  • Grifols, S.A. (GIFLF)
  • Grifols, S.A. (GIFOF)
  • M3, Inc. (MTHRF)
  • M3, Inc. (MTHRY)
  • Recordati Industria Chimica e Farmaceutica S.p.A. (RCDTF)
  • Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)
  • Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)
  • Sysmex Corporation (SSMXF)

Open Bangkok Dusit Medical Services Public Company Limited (BDUUF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.